Targeting Pyruvate Kinase M2 As a Novel Therapeutic Strategy Against Liver Fibrosis and Hepatocellular Carcinoma

被引:0
|
作者
Zheng, Dandan [1 ]
Lin, Zelong [1 ,2 ]
Hu, Kaishun [3 ]
Lan, Tian [4 ]
Holmes, Jacinta A. [5 ,6 ,7 ]
Song, Zhenghui [2 ,8 ]
He, Lu [1 ]
Jiang, Yuchuan [1 ]
Chen, Peng [1 ,2 ]
Tu, Mengxian [1 ]
Chen, Hengxing [3 ]
Hu, Qiaoting [1 ]
Qu, Chen [1 ,2 ]
Lin, Wenyu [5 ,6 ,7 ]
Li, Aimin [2 ,8 ]
Chung, Raymond T. [5 ,6 ,7 ]
Hong, Jian [1 ,2 ]
机构
[1] Southern Med Univ, Integrated Hosp Tradit Chinese Med, Dept Abdominal Surg, Guangzhou, Guangdong, Peoples R China
[2] Southern Med Univ, Canc Ctr, Guangzhou, Guangdong, Peoples R China
[3] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Guangzhou, Guangdong, Peoples R China
[4] Guangdong Pharmaceut Univ, Guangzhou, Guangdong, Peoples R China
[5] Massachusetts Gen Hosp, Liver Ctr, Boston, MA 02114 USA
[6] Massachusetts Gen Hosp, Gastrointestinal Div, Boston, MA 02114 USA
[7] Harvard Med Sch, Boston, MA USA
[8] Southern Med Univ, Integrated Hosp Tradit Chinese Med, Dept Hepatol, Guangzhou, Guangdong, Peoples R China
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
1120
引用
收藏
页码:646A / 647A
页数:2
相关论文
共 50 条
  • [41] Cancer metabolism control by natural products: Pyruvate kinase M2 targeting therapeutics
    El-Far, Ali H.
    Al Jaouni, Soad K.
    Li, Xiaotao
    Fu, Junjiang
    PHYTOTHERAPY RESEARCH, 2022, 36 (08) : 3181 - 3201
  • [42] Pyruvate kinase M2 inhibits the progression of bladder cancer by targeting MAKP pathway
    Zhu, Qiang
    Hong, Baofa
    Zhang, Lei
    Wang, Jing
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2018, 14 : S616 - S621
  • [43] Potential adverse effects to the retina of cancer therapy targeting pyruvate kinase M2
    Ng, Soo Khai
    Wood, John P. M.
    Chidlow, Glyn
    Peet, Daniel J.
    Casson, Robert J.
    ACTA ONCOLOGICA, 2015, 54 (01) : 136 - 137
  • [44] Protein kinase function of pyruvate kinase M2 and cancer
    Xun Chen
    Shangwu Chen
    Dongsheng Yu
    Cancer Cell International, 20
  • [45] Protein kinase function of pyruvate kinase M2 and cancer
    Chen, Xun
    Chen, Shangwu
    Yu, Dongsheng
    CANCER CELL INTERNATIONAL, 2020, 20 (01)
  • [46] Analysis on in-Silico Identification of Novel Activator of Pyruvate Kinase M2
    Sharma, Pankaj
    Singh, Manvender
    Sharma, Sangeeta
    BIOSCIENCE BIOTECHNOLOGY RESEARCH COMMUNICATIONS, 2021, 14 (01): : 236 - 242
  • [47] Pyruvate kinase M2 is a poor prognostic marker of and a therapeutic target in ovarian cancer
    Chao, Tai-Kuang
    Huang, Tien-Shuo
    Liao, Yu-Ping
    Huang, Rui-Lan
    Su, Po-Hsuan
    Shen, Hueng-Yuan
    Lai, Hung-Cheng
    Wang, Yu-Chi
    PLOS ONE, 2017, 12 (07):
  • [48] PYRUVATE KINASE TYPE M2: A TARGET OF DIFFERENT ONCOGENES WITH HIGH THERAPEUTIC POTENTIAL
    Mazurek, S.
    Zwerschke, W.
    Rapp, U.
    Rosa, J. L.
    Eigenbrodt, E.
    ANTICANCER RESEARCH, 2008, 28 (5C) : 3400 - 3401
  • [49] Design and synthesis of novel JNK inhibitors targeting liver pyruvate kinase for the treatment of non-alcoholic fatty liver disease and hepatocellular carcinoma
    Iqbal, Shazia
    Sebhaoui, Jihad
    Ashraf, Sajda
    Ozcan, Mehmet
    Kim, Woonghee
    Belmen, Burcu
    Yesilyurt, Guldeniz
    Hanashalshahaby, Essam
    Zhang, Cheng
    Uhlen, Mathias
    Boren, Jan
    Turkez, Hasan
    Mardinoglu, Adil
    BIOORGANIC CHEMISTRY, 2024, 147
  • [50] Pharmacological inhibition of Axl tyrosine kinase as a novel therapeutic strategy in hepatocellular carcinoma
    Pinato, David James
    Trousil, Sebastian
    Caley, Matthew
    Mauri, Francesco A.
    Aboagye, Eric
    Sharma, Rohini
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)